Total Payments
$2,236
2024 Payments
$943.68
Companies
38
Transactions
119
Medicare Patients
7,037
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$2,222 (99.4%)
Education$13.80 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,222 | 118 | 99.4% |
| Education | $13.80 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $276.43 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $178.72 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $168.16 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $152.31 | 8 | $0 (2024) |
| Exelixis Inc. | $149.83 | 9 | $0 (2024) |
| ABBVIE INC. | $126.47 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $125.55 | 6 | $0 (2024) |
| BeiGene USA, Inc. | $101.71 | 6 | $0 (2024) |
| GENZYME CORPORATION | $98.58 | 4 | $0 (2024) |
| Eisai Inc. | $98.36 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $943.68 | 43 | Merck Sharp & Dohme LLC ($130.03) |
| 2023 | $748.07 | 40 | Novartis Pharmaceuticals Corporation ($96.24) |
| 2022 | $313.51 | 21 | Janssen Biotech, Inc. ($41.15) |
| 2021 | $60.49 | 3 | Acceleron Pharma, Inc. ($23.61) |
| 2020 | $43.15 | 3 | Daiichi Sankyo Inc. ($17.90) |
| 2019 | $116.63 | 8 | Janssen Biotech, Inc. ($18.28) |
| 2018 | $10.43 | 1 | Sirtex Medical Inc ($10.43) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/13/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 08/23/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Oncology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Oncology | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Oncology | ||||||
| 06/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/15/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Hematology/Oncology | ||||||
| 05/01/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,635 | 4,443 | $1.2M | $338,448 |
| 2022 | 17 | 1,547 | 5,072 | $1.2M | $345,315 |
| 2021 | 18 | 2,047 | 5,508 | $1.3M | $418,252 |
| 2020 | 19 | 1,808 | 4,479 | $1.0M | $348,862 |
Total Patients
7,037
Total Services
19,502
Medicare Billing
$1.5M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 174 | 743 | $332,714 | $103,582 | 31.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 97 | 1,394 | $171,045 | $46,097 | 27.0% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 91 | 103 | $86,496 | $32,190 | 37.2% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 191 | 210 | $84,503 | $25,792 | 30.5% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 201 | 530 | $104,988 | $23,802 | 22.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 93 | 121 | $56,577 | $20,125 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 117 | 117 | $41,842 | $15,287 | 36.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 174 | 544 | $77,228 | $13,220 | 17.1% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 75 | 75 | $52,231 | $12,320 | 23.6% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Facility | 2023 | 20 | 21 | $26,482 | $9,696 | 36.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 107 | 150 | $26,823 | $9,084 | 33.9% |
| 77331 | Special radiation therapy planning | Facility | 2023 | 66 | 178 | $30,080 | $5,926 | 19.7% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Facility | 2023 | 49 | 50 | $15,536 | $5,711 | 36.8% |
| 77470 | Special radiation treatment | Facility | 2023 | 61 | 64 | $18,464 | $5,086 | 27.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 19 | 36 | $13,752 | $4,910 | 35.7% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Facility | 2023 | 24 | 25 | $7,006 | $1,950 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 28 | $3,180 | $1,308 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,332 | $1,182 | 35.5% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 39 | 42 | $3,289 | $1,179 | 35.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 186 | 791 | $345,218 | $110,780 | 32.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 118 | 2,040 | $234,293 | $67,847 | 29.0% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 172 | 543 | $107,108 | $24,592 | 23.0% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 170 | 188 | $73,641 | $23,191 | 31.5% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 65 | 70 | $58,257 | $22,077 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 122 | 122 | $42,292 | $16,507 | 39.0% |
About Dr. Kevin Collins, MD
Dr. Kevin Collins, MD is a Radiation Oncology healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174611511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Collins, MD has received a total of $2,236 in payments from pharmaceutical and medical device companies, with $943.68 received in 2024. These payments were reported across 119 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($2,222).
As a Medicare-enrolled provider, Collins has provided services to 7,037 Medicare beneficiaries, totaling 19,502 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology, Radiation Oncology
- Location Union City, TN
- Active Since 10/11/2006
- Last Updated 06/22/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1174611511
Products in Payments
- KEYTRUDA (Biological) $248.29
- CABOMETYX (Drug) $136.89
- BRUKINSA (Drug) $101.71
- Lenvima (Drug) $98.36
- ENHERTU (Biological) $95.66
- SARCLISA (Biological) $86.06
- IMBRUVICA (Drug) $85.93
- VENCLEXTA (Drug) $79.48
- Enhertu (Drug) $73.52
- VERZENIO (Drug) $64.37
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $63.37
- PLUVICTO (Drug) $62.93
- GILOTRIF (Drug) $56.30
- LYNPARZA (Drug) $53.14
- INJECTAFER (Drug) $52.03
- DARZALEX (Biological) $45.85
- FOTIVDA (Drug) $41.39
- AYVAKIT (Drug) $38.44
- TABRECTA (Drug) $36.65
- LUMAKRAS (Drug) $32.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.